Skip to search boxSkip to navigationSkip to main content

Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells

  • H. Yeoman
    ,
  • A. L. Mellor(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Transgenic mice carrying a MHC class I structural gene (H-2Kb) linked to transcriptional control elements from the human β-globln gene, which direct erythroid lineage specific transcription, express H-2Kb molecules In red blood cells but H-2Kb expression cannot be detected in skin or lymphoid cells. This limited pattern of self MHC expression is sufficient to Induce tolerance to H-2Kb molecules and H-2Kb restricted cytotoxic T cell responses can be generated in transgenic mice. Transgenic mice are unable to mount H-2Kb specific cytotoxic T cell responses in vitro, even when exogenous IL-2 is provided. However, H-2Kb specific T cell proliferative responses are comparable with H-2Kb specific responses in non-transgenic mice, even in the absence of exogenous IL-2. Thus, expression of H-2Kb molecules under control of human β-globln transcriptional control elements In transgenic mice is tolerogenlc but does not result in elimination of all H-2Kb reactive T cells from the mature repertoire. This suggests that tolerance In these mice may arise due to functional inactivation of H-2Kb reactive T cells in vivo when they encounter H-2Kb molecules expressed on cells of erythroid cell lineages or on non-erythroid cells which express H-2Kb molecules at very low levels or in a developmentally regulated pattern. Furthermore, In spite of the failure to detect H-2Kb expression on non-erythrold cells In these mice, we conclude that H-2Kb molecules participate In positive selection of the T cell repertoire since H-2Kb restricted T cell responses can be generated in these transgenic mice.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 59-65 (7 pages)

Journal (Volume, Issue Number)

International Immunology (Volume 4, Issue 1)

Publication milestones

  • Published - 01/1992

Publication status

Published - 01/1992

ISSN

0953-8178

Publication IDs

  • Scopus: 0026503761
  • PubMed: 1540549

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
38
Captures
1